DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Amarin Corporation PLC (AMRN)
« Back to company indexAMRN Chatter Timeline
Stock Ticker for AMRN
Most Active Tweeters for AMRN
| User | Tweets |
|---|---|
| @MedResCol | 21 |
| @sales_js | 21 |
| @TheStockPanther | 16 |
| @MarketPimp | 13 |
| @1MinuteStock | 12 |
Recent Tweets for AMRN
 |
@joaquinkam RT @TerraPharma1: $AMRN New US patent application published late last week (on website today) for combo with mipomersen (brand name Kynamro… October 21st 2019, 8:10pm |
 |
@monroewarriors5 @haodongvli $AMRN next! October 21st 2019, 5:10pm |
 |
@chriskemprealty Good info in here on $AMRN https://t.co/ZsTPyfHZ1C October 21st 2019, 5:10pm |
 |
@tabuhasna RT @bio_econ: ~ strong recommendation to watch this: https://t.co/XyCXA5Um8q ~ $AMRN $ACST ~ big thanks to @MatthewLepoire and Nathan We… October 21st 2019, 5:10pm |
 |
@sansing_david Great article on $AMRN - A Chat With John Thero, CEO Of Amarin. https://t.co/GtPNBGKHoj October 21st 2019, 5:10pm |
 |
@moshakes_911 @stockmktgenius @realwillmeade and $AMRN October 21st 2019, 4:10pm |
 |
@MedResCol See, everyone gets a voice: $AMRN https://t.co/pj4B11rRrY October 21st 2019, 4:10pm |
 |
@StonesCapital $AMRN He seems pretty optimistic about this presentation!! #Vascepa https://t.co/JPTPBYC5KZ October 21st 2019, 4:10pm |
 |
@TraderJill77 Informal chat with $AMRN CEO https://t.co/cGatrCD5xl October 21st 2019, 4:10pm |
 |
@TerraPharma1 $AMRN New US patent application published late last week (on website today) for combo with mipomersen (brand name K… https://t.co/dasIrz0KWH October 21st 2019, 3:10pm |
 |
@75234j RT @TerraPharma1: A Chat with $AMRN CEO John Thero https://t.co/oIrmekDgJa October 21st 2019, 2:10pm |
 |
@tommyrulznyc @workin4thefam @TerraPharma1 If $amrn is locking up all the “good” fish, what’s in that OTC crap??? ? October 21st 2019, 2:10pm |
 |
@PickingMyOwn RT @MatthewTNatale: $AMRN "A Chat With John Thero, CEO Of Amarin" https://t.co/yBqV2BlaVs $AMRN October 21st 2019, 2:10pm |
 |
@TOWiU2 @portefeuillefun What is the background of the remarkable difference in top10 positions of the real portfolio vs. vssporte, e.g. $amrn? October 21st 2019, 1:10pm |
 |
@ArikCR23 $AMRN Anyone who supports AMRN must block Medical Research Collaborative, LLC he just doesn't bring any value in hi… https://t.co/4ItD4qBxYB October 21st 2019, 1:10pm |
 |
@MatthewTNatale $AMRN "A Chat With John Thero, CEO Of Amarin" https://t.co/yBqV2BlaVs $AMRN October 21st 2019, 1:10pm |
|
@TerraPharma1 A Chat with $AMRN CEO John Thero https://t.co/oIrmekDgJa October 21st 2019, 1:10pm |
 |
@Arbtrader69 $AMRN - A Chat With John Thero, CEO Of Amarin. https://t.co/E655Uwgj0e October 21st 2019, 1:10pm |
|
@tabuhasna A Chat With John Thero, CEO Of Amarin $AMRN https://t.co/mXlz9ELV2E October 21st 2019, 1:10pm |
 |
@SeekingAlpha $AMRN - A Chat With John Thero, CEO Of Amarin. Sign up for updates on Seeking Alpha! https://t.co/UQBbSm0Yjd #stockmarket #finance #stocks October 21st 2019, 1:10pm |
 |
@sales_js RT @TraderJill77: The AdComm for $AMRN is Nov 14th for an expanded Vascepa label. It is one of mine, and I've been holding since this summe… October 21st 2019, 1:10pm |
|
@sales_js RT @greenday_bio: $AMRN The call for Vascepa expanded approval from cardiologists / endocrinologists keep pouring in https://t.co/E3I5ZFNB1… October 21st 2019, 1:10pm |
|
@PickingMyOwn RT @greenday_bio: @TerraPharma1 $AMRN has their own reply to the question https://t.co/G7TIq2yk8P October 21st 2019, 12:10pm |
 |
@greenday_bio @TerraPharma1 $AMRN People are starting to realize the magnitude of this. Vascepa usage could be so big there might… https://t.co/foV6IkD0Dj October 21st 2019, 12:10pm |
|
@greenday_bio @TerraPharma1 $AMRN has their own reply to the question https://t.co/G7TIq2yk8P October 21st 2019, 12:10pm |
|
@TraderJill77 The AdComm for $AMRN is Nov 14th for an expanded Vascepa label. It is one of mine, and I've been holding since this… https://t.co/MyWFXnnXwI October 21st 2019, 11:10am |
|
@greenday_bio $AMRN The call for Vascepa expanded approval from cardiologists / endocrinologists keep pouring in… https://t.co/gIZZvrypoh October 21st 2019, 11:10am |
 |
@bio_econ ~ strong recommendation to watch this: https://t.co/XyCXA5Um8q ~ $AMRN $ACST ~ big thanks to @MatthewLepoire and Nathan Weinstein. October 21st 2019, 11:10am |
|
@TerraPharma1 ESC Debate - it’s the Triglycerides, Pros vs Cons. $AMRN #reduceit #vascepa #omega3 #icosapentethyl https://t.co/xF5FUqVAE1 October 21st 2019, 11:10am |
 |
@glareone $AMRN Monthy target https://t.co/5JyEQtPBgx October 21st 2019, 9:10am |
|
@MatthewTNatale $AMRN So-so article but it's 100% correct! Future isn't promised but that doesn't mean there isn't a pony in the b… https://t.co/Lpg3fSjByM October 21st 2019, 9:10am |
|
@joaquinkam RT @BullLogic: $AMRN $30 coming. Believe it. October 21st 2019, 8:10am |
 |
@FaZe_VascepA This guy shud quit #10bomb #sbmmTrash $AMRN Vascepa wins #Fortnite #XboxShare https://t.co/1HglgPRuX4 October 21st 2019, 8:10am |
 |
@JohnCappello Pleiotropic health benefits of EPA beyond CVD $AMRN "Protective effects of Eicosapentaenoic acid in adipocyte-br… https://t.co/m4wtrZ5d3c October 21st 2019, 7:10am |
 |
@tradejas POSITIVE SCRIPTS for Week Ending 10/11/2019...from IHub by rafunrafun | $AMRN Message Board Posts https://t.co/BNMGjqr8BL October 21st 2019, 7:10am |
 |
@IRAMarketReport Recent Investment Analysts’ Ratings Changes for Amarin $AMRN https://t.co/MjGItCousF #markets October 21st 2019, 6:10am |
 |
@chaffeybreeze Recent Investment Analysts’ Ratings Changes for Amarin $AMRN https://t.co/s1XENL9CDP #stocks October 21st 2019, 6:10am |
 |
@ConsumerFeed Recent Investment Analysts’ Ratings Changes for Amarin $AMRN https://t.co/pADlEnpCA8 October 21st 2019, 6:10am |
 |
@AmericanBanking Recent Investment Analysts’ Ratings Changes for Amarin $AMRN https://t.co/Dpe7JvrvWa #stocks October 21st 2019, 5:10am |
 |
@WeekHerald Amarin $AMRN Rating Increased to Buy at Zacks Investment Research https://t.co/F359p1HOlY October 21st 2019, 4:10am |
 |
@registrarjourn Zacks Investment Research Lowers Amarin $AMRN to Hold https://t.co/Tz1MUAxrcW October 21st 2019, 4:10am |
 |
@EnterpriseLeade Zacks Investment Research Lowers Amarin $AMRN to Hold https://t.co/Peh6UwZaqX October 21st 2019, 4:10am |
 |
@dispatchtribune Zacks Investment Research Lowers Amarin $AMRN to Hold https://t.co/kEl7EOYua3 October 21st 2019, 4:10am |
 |
@OlympiaReport Amarin $AMRN Rating Increased to Buy at Zacks Investment Research https://t.co/rpH6187SLU October 21st 2019, 4:10am |
|
@tabuhasna RT @MatthewLepoire: $ACST $AMRN https://t.co/Xlh3925Idv October 21st 2019, 3:10am |
 |
@dailypoliticaln Amarin $AMRN Stock Rating Upgraded by BidaskClub https://t.co/TpN2w6h2ue October 21st 2019, 3:10am |
 |
@ZolmaxNews Amarin $AMRN Stock Rating Upgraded by BidaskClub https://t.co/E7XXX42fct October 21st 2019, 3:10am |
|
@WeekHerald Amarin $AMRN Given a $35.00 Price Target by Cantor Fitzgerald Analysts https://t.co/sjOtnK0W95 October 21st 2019, 1:10am |
|
@OlympiaReport Amarin $AMRN Given a $35.00 Price Target by Cantor Fitzgerald Analysts https://t.co/Xcs1fFSI9U October 21st 2019, 1:10am |
 |
@MatthewLepoire $ACST $AMRN https://t.co/Xlh3925Idv October 21st 2019, 1:10am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.